In this Dec. 1, 2014 file photo a man makes a call on a mobile phone as he passes World AIDS Day banners on the perimeter of an office building in Sandton, Johannesburg, South Africa. A new vaccine against HIV, called HVTN 702, is to be tested in South Africa, it is announced Sunday Nov. 27, 2016, and scientists aims to enroll 5,400 sexually active men and women for the clinical trial. (AP Photo/Denis Farrell, File)
The first HIV vaccine trial in almost a decade is launching Wednesday in South Africa to experimentally test the efficacy of a new vaccine regimen in preventing the spread of the deadly disease, which infects more than 1,000 South Africans a day.
The study, called HVTN 702, aims to enroll 5,400 HIV-uninfected, sexually active men and women aged 18 to 35 years. Conducted at 15 sites across South Africa, the study participants will be randomly assigned …